fincash logo SOLUTIONS

Fincash » Search » Sequent Scientific Ltd

Sequent Scientific Ltd

Updated on October 15, 2020

Stock/Share Code - SEQUENT

SeQuent Scientific is a pharmaceutical company. Its segments include Pharmaceuticals, Speciality Chemicals and Analytical Services. It focuses on products for livestock, poultry and companion animals.

Below is the details of SEQUENT Sequent Scientific Ltd

Market Cap₹3,221 Cr.
Current Price ₹154.25 as on 21 Oct 20
52 Week High / Low Price₹145.55 / ₹51.7
Face Value₹2
Stock P/E120.07
Book Value₹35.68
Dividend Yield0.15 %
ROCE2.96 %
ROE2.37 %
Sales Growth (3yrs)35.83 %
IndustryPharmaceuticals - Indian - Bulk Drugs
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is virtually debt free. Company has been maintaining a healthy dividend payout of 22.08% Debtor days have improved from 143.28 to 65.49 days.
Cons: Stock is trading at 3.63 times its book value Promoter holding has decreased by -1.32% over last quarter Tax rate seems low Promoters have pledged 44.60% of their holding. Earnings include an other income of Rs.14.75 Cr.

Sequent Scientific Ltd Price Chart

Sequent Scientific Ltd Price Chart

Sequent Scientific Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Divi's Lab. ₹141 51.94 ₹82,900.53 Cr. 0.51 ₹492.06 Cr. 80.61 48.81 1730.47 25.19
2. Lupin ₹1,002.55 ₹42,032.3 Cr. 0.65 ₹106.9 Cr. -64.73 -9.02 3527.86 9.23
3. Jubilant Life ₹706.05 13.50 ₹12,477.17 Cr. 0.64 ₹260.49 Cr. 248.25 0.24 2391.41 15.46
4. Granules India ₹386.35 22.60 ₹7,765.53 Cr. 0.32 ₹111.45 Cr. 33.89 23.57 735.60 17.15
5. Aarti Drugs ₹769.1 31.46 ₹6,319.31 Cr. 0.07 ₹85.45 Cr. 280.62 34.34 544.67 20.87
6. Shilpa Medicare ₹469.25 23.66 ₹4,289.13 Cr. 0.21 ₹86.31 Cr. 159.66 38.43 222.86 12.62
7. Sequent Scien. 120.07 ₹3,221.37 Cr. 0.15 ₹6.91 Cr. 386.62 14.54 59.24 2.96
8. Hikal ₹168.8 23.23 ₹2,004.25 Cr. 0.74 ₹15 Cr. -40.55 -12.50 352.77 13.51

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Sequent Scientific Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020
Sales -26.4426.7226.8026.2936.2448.1455.5951.7251.5261.8062.2959.24
YOY Sales Growth %-71.20%-9.08%0.56%0.92%37.07%80.16%107.43%96.73%42.16%28.38%12.05%14.54%
Expenses -32.4132.1232.3827.1436.2546.6853.0948.6848.6655.9451.7549.46
Material Cost %94.89%58.76%75.19%67.78%51.90%53.10%58.34%54.49%53.28%50.39%42.17%44.58%
Employee Cost %15.09%8.98%6.83%6.01%7.23%6.75%5.86%6.63%8.33%8.11%7.03%8.88%
Operating Profit-5.97-5.40-5.58-0.85-0.011.462.503.042.865.8610.549.78
OPM %-22.58%-20.21%-20.82%-3.23%-0.03%3.03%4.50%5.88%5.55%9.48%16.92%16.51%
Other Income19.064.49400.264.364.573.021.612.
Profit before tax12.20-1.92393.462.622.710.860.011.426.644.6910.058.80
Tax %0.00%-27.08%0.60%0.00%0.00%0.00%-13,800.00%0.00%-53.31%37.74%32.24%21.36%
Net Profit12.20-2.44391.122.622.710.871.391.4210.182.926.826.91
EPS in Rs0.50-0.1016.

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020TTM
Sales -10624627833223634138439591106166227235
Sales Growth %57.36%132.26%12.84%19.59%-29.08%44.61%12.70%2.69%-77.01%16.87%56.83%36.73%
Expenses -94187231297253347331358121126164205206
Material Cost %47.85%42.11%50.46%57.12%56.18%55.34%50.28%55.45%79.96%74.88%56.91%49.73%
Manufacturing Cost %19.96%16.00%15.79%12.82%20.00%19.20%16.10%15.78%18.42%16.68%29.14%27.84%
Employee Cost %8.23%8.20%8.17%7.65%12.34%9.84%10.37%9.84%19.73%11.18%6.44%7.52%
Other Cost %12.58%9.78%8.68%11.74%18.91%17.37%9.41%9.77%15.58%15.71%5.89%5.12%
Operating Profit12594735-18-65336-31-2032229
OPM %11%24%17%11%-7%-2%14%9%-34%-18%2%10%12%
Other Income2312112-55581534433141515
Profit before tax63022-2-63-1144310-040962330
Tax %36%32%28%159%13%0%4%1%0%1%-22%6%
Net Profit421161-54-1144110-040682127
EPS in Rs0.601.891.450.
Dividend Payout %32%20%20%0%0%0%0%0%0%1%65%0%

Compounded Sales Growth

  • 10 Years:: -0.80%
  • 5 Years:: -9.97%
  • 3 Years:: 35.83%
  • TTM:: 22.52%

Compounded Profit Growth

  • 10 Years:: -0.77%
  • 5 Years:: -19.58%
  • 3 Years:: 1187.86%
  • TTM:: 319.87%

Return on Equity

  • 10 Years:: 18.54%
  • 5 Years:: -3.87%
  • 3 Years:: 5.95%
  • 1 Year:: 67.88%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Share Capital -112121212327304849494950
Equity Capital11.0921.2421.2421.3423.4426.7430.4947.6548.7548.7549.3749.67
Other Liabilities -2788120148177171181107106295775
Trade Payables155578123146135707470255364
Advance from Customers003421111000
Other liability items12333921303411133354411
Total Liabilities1363414214965405606501,3481,4509771,019997
Fixed Assets -45118189206205220201170188245269
Gross Block57150240276301338302193237387399
Accumulated Depreciation12325070961181012349142130
Other Assets -64156205233259264257262340264178167
Trade receivables2045538270809974113784341
Cash Equivalents41261631192753324
Loans n Advances19534562355960128142402526
Other asset items-0-240104055-1191298364
Total Assets1363414214965405606501,3481,4509771,019997

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Cash from Operating Activity -11304910-13-42-25100-24-47430
Profit from operations12.7762.8244.3239.81-1.7721.7865.5444.0320.2916.534.0124.56
Other WC items0.000.000.00-8.48-6.659.99-1.622.541.83-0.181.24-0.03
Working capital changes-0.82-31.0410.05-26.13-11.41-63.79-89.2256.92-42.97-21.1070.327.84
Direct taxes-1.31-2.04-5.60-3.280.48-0.36-1.31-0.93-1.360.55-0.54-2.19
Cash from Investing Activity --29-28-68-40-31-6124-359-4716-114-10
Fixed assets purchased-6.35-23.94-52.42-25.80-30.03-39.48-69.49-24.82-44.950.00-3.17-5.39
Fixed assets sold0.000.370.2511.962.194.26152.340.630.002.600.010.00
Investments purchased0.00-0.39-0.17-
Investments sold0.6512.800.
Interest received0.370.931.664.231.941.560.646.2110.403.830.540.84
Dividends received0.
Invest in subsidiaries-4.95-14.57-1.02-
Loans to subsidiaries0.
Investment in group cos0.
Other investing items-18.77-3.58-16.86-5.6911.17-0.847.76-60.44-17.94-32.22-35.037.30
Cash from Financing Activity -187133239108824771-1240-18
Proceeds from shares0.
Proceeds from borrowings23.9734.3737.7629.1841.36101.6170.384.5048.184.0162.8823.62
Repayment of borrowings0.00-9.560.0032.92-10.59-8.57-78.78-288.73-9.89-6.91-20.00-33.05
Interest paid fin-3.97-16.02-19.94-26.79-29.19-39.00-45.74-16.61-7.87-3.76-3.22-4.85
Dividends paid-1.39-1.11-4.25-
Other financing items-0.23-0.58-0.72-0.5511.8710.6628.818.200.00-0.990.00-0.97
Net Cash Flow-08-72-547-120-002

Ready to Invest?
Talk to our investment specialist
By submitting this form I authorize to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.


Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
ROCE %10%30%14%6%-11%-6%26%3%0%35%1%3%
Debtor Days676770911098594684552709465
Inventory Turnover3.083.432.883.372.062.292.543.851.

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Sequent Scientific Ltd & Get More Returns than Bank Deposit

All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.